People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157 Banned: Key Facts on the Latest FDA Decision The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Regulation of Dietary Supplements and Other Specialized Categories